Patrick Starlinger

Title: Patrick Starlinger: Innovator in Liver Dysfunction Prediction

Introduction

Patrick Starlinger is an inventor based in Austria, known for his contributions to the field of medical diagnostics. His work focuses on innovative methods for predicting liver dysfunction, particularly after partial liver resection. Although he currently holds no patents, his research has significant implications for patient care and treatment strategies.

Latest Patents

Starlinger's notable invention is titled "Micro-RNA Signatures For The Prediction Of Liver Dysfunction." This invention relates to an in vitro method that determines a subject's risk of liver dysfunction. The method involves providing a sample from the subject and determining the expression level of specific microRNAs, including miR-151a, miR-192, and miR-122. By comparing these expression levels with reference levels, the method classifies the risk into "high-risk" and "low-risk" categories.

Career Highlights

Throughout his career, Patrick Starlinger has focused on advancing medical diagnostics. His research has contributed to a better understanding of liver dysfunction and its implications for surgical patients. His innovative approach to using microRNA signatures represents a significant step forward in personalized medicine.

Collaborations

Starlinger has collaborated with Alice Assinger, a fellow researcher, to enhance the development of his diagnostic methods. Their partnership has fostered a productive exchange of ideas and expertise, furthering the impact of their work in the medical field.

Conclusion

Patrick Starlinger is a dedicated inventor whose work in predicting liver dysfunction has the potential to transform patient outcomes. His innovative methods highlight the importance of research in advancing medical diagnostics.